Vascular pro-oxidant effects related to the autoxication of dopamine

Free Radical Research

Volumn 43, Issue 3, 2009, Pages 295-303

  Fernández Ferreiro, Álvaro ^a   Gil Longo, Jośe ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Autoxidation; Dopamine; Hydrogen peroxide; Quinones; Rat aorta

Indexed keywords

CATALASE; DOPAMINE; GLUTATHIONE; HYDROGEN PEROXIDE; INDOMETACIN; LACTATE DEHYDROGENASE; OXYGEN; PHENYLEPHRINE; POTASSIUM CHLORIDE; PROSTAGLANDIN SYNTHASE; QUINONE DERIVATIVE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; AUTOOXIDATION; BLOOD VESSEL TONE; CELL DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; FEMALE; NONHUMAN; OXYGENATION; PH; RAT; TEMPERATURE; TIME; VASCULAR ENDOTHELIUM; VASCULAR RING; VASOCONSTRICTION; VASODILATATION;

ANIMALS; AORTA, THORACIC; CATALASE; DOPAMINE; FEMALE; HUMANS; HYDROGEN PEROXIDE; INDOMETHACIN; L-LACTATE DEHYDROGENASE; MUSCLE CONTRACTION; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; POTASSIUM CHLORIDE; RATS; RATS, INBRED WKY; SPECTROPHOTOMETRY, ULTRAVIOLET;

RATTUS;

EID: 61849100928     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760802712608     Document Type: Article

References (31)

1. Graham, DG, Tiffany, SM, Bell Jr, WR and Gutknecht, WF. (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol, 14, pp. 644-653.
2. Herlinger, E., Jameson, RF and Linert, W. (1995) Spontaneous autoxidation of dopamine. J Chem Soc [Perkin II], 2, pp. 259-263.
3. Graumann, R., Paris, I., Martinez, P., Rumanque, P., Marin, P., Diaz-Grez, F., Caviedes, R., Caviedes, P. and Segura-Aguilar, J. (2002) Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase. Pol J Pharmacol, 54, pp. 573-579.
4. Ikemoto, K., Nagatsu, I., Ito, S., King, RA, Nishimura, A. and Nagatsu, T. (1998) Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra?. Neurosci Lett, 253, pp. 198-200.
5. Zecca, L., Tampellini, D., Gerlach, M., Riederer, M., Fariello, RG and Sulzer, D. (2001) Substantia nigra neuromelanin: Structure, synthesis, and molecular behaviour. J Clin Pathol Mol Pathol, 54, pp. 414-418.
6. Bisaglia, M., Mammi, S. and Bubacco, L. (2007) Kinetic and structural analysis of the early oxidation products of dopamine. Analysis of the interactions with β-synuclein. J Biol Chem, 282, pp. 15597-15605.
7. Costa, C., Bertazzo, A., Allegri, G., Toffano, G., Curcuruto, O. and Traldi, P. (1992) Melanin biosynthesis from dopamine. II. A mass spectrometric and collisional spectroscopic investigation. Pigment Cell Res, 5, pp. 122-131.
8. Asanuma, M., Miyazaki, I., Diaz-Corrales, FJ and Ogawa, N. (2004) Quinone formation as dopaminergic neuron-specific oxidative stress in pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism. Acta Med Okayama, 58, pp. 221-233.
9. Hermida-Ameijeiras, A., Mendez-Alvarez, E., Sanchez-Iglesias, S., Sanmartin-Suarez, C. and Soto-Otero, R. (2004) Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: Role of ferrous and ferric ions. Neurochem Inter, 45, pp. 103-116.
10. Stokes, AH, Hastings, TG and Vrana, KE. (1999) Cytotoxic and genotoxic potential of dopamine. J Neurosci Res, 55, pp. 659-665.
11. Pattison, DI, Dean, RT and Davies, MJ. (2002) Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechol(amine)s. Toxicology, 177, pp. 23-37.
12. Chen, L., Ding, Y., Cagniard, B., Van Laar, AD, Mortimer, A., Chi, A., Hastings, TG, Kang, UJ and Zhuang, X. (2008) Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J Neurosci, 28, pp. 425-433.
13. Ito, S., Kato, T. and Fujita, K. (1988) Covalent binding of catechols to proteins through the sulphydryl group. Biochem Pharmacol, 37, pp. 1707-1710.
14. Haque, ME, Asanuma, M., Higashi, Y., Miyazaki, I., Tanaka, K. and Ogawa, N. (2003) Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells. Biochim Biophys Acta, 1619, pp. 39-52.
15. Pedrosa, R. and Soares-Da-Silva, P. (2002) Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine. Br J Pharmacol, 137, pp. 1305-1313.
16. Siraki, AG, Smythies, J. and O'Brien, PJ. (2000) Superoxide radical scavenging and attenuation of hypoxia-reoxygenation injury by neurotransmitter ferric complexes in isolated rat hepatocytes. Neurosci Lett, 296, pp. 37-40.
17. Buhmann, C., Arlt, S., Kontush, A., Moller-Bertram, T., Sperber, S., Oechsner, M., Stuerenburg, HJ and Beisiegel, U. (2004) Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication. Neurobiol Dis, 15, pp. 160-170.
18. Angus, JA, Cocks, TM and Satoh, K. (1986) β2-adrenoceptors and endothelium-dependent relaxation in canine large arteries. Br J Pharmacol, 88, pp. 767-777.
19. Graham, DG. (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol, 14, pp. 633-643.
20. Meredith, P., Powell, BJ, Riesz, J., Nighswander-Rempel, SP, Pederson, MR and Moore, EG. (2006) Towards structure-property-function relationships for eumelanin. Soft Matter, 2, pp. 37-44.
21. Dagnino-Subiabre, A., Cassels, BK, Baez, S., Johansson, A-S, Mannervik, B. and Segura-Aguilar, J. (2000) Glutathione transferase M2-2 catalyzes conjugation of dopamine and dopa o-quinones. Biochem Biophys Res Commun, 274, pp. 32-36.
22. Gil-Longo, J. and Gonzalez-Vazquez, C. (2005) Characterization of four different effects elicited by H2O2 in rat aorta. Vascul Pharmacol, 43, pp. 128-138.
23. Varma, DR and Chemtob, S. (1993) Endothelium- and beta-2 adrenoceptor-independent relaxation of rat aorta by tyramine and certain other phenylethylamines. J Pharmacol Exp Ther, 265, pp. 1096-1104.
24. Gao, YJ, Hirota, S., Zhang, DW, Janssen, LJ and Lee, RMKW. (2003) Mechanisms of hydrogen-peroxide-induced biphasic response in rat mesenteric artery. Br J Pharmacol, 138, pp. 1085-1092.
25. Hayer-Zillgen, M., Bruss, M. and Bonisch, H. (2002) Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol, 136, pp. 829-836.
26. Li, J., Li, W., Su, J., Liu, W., Altura, BT and Altura, BM. (2003) Hydrogen peroxide induces apoptosis in cerebral vascular smooth muscle cells: Possible relation to neurodegenerative diseases and strokes. Brain Res Bull, 62, pp. 101-106.
27. LeBlanc, J. and Ducharme, MB. (2007) Plasma dopamine and noradrenaline variations in response to stress. Physiol Behav, 91, pp. 208-211.
28. Garris, PA, Ciolkowski, EL, Pastore, P. and Wightman, RM. (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci, 14, pp. 6084-6093.
29. Mac Gregor, DA, Smith, TE, Prielipp, RC, Butterworth, JF, James, RL and Scuderi, PE. (2000) Pharmacokinetics of dopamine in healthy male subjects. Anesthesiology, 92, pp. 338-346.
30. Dethy, S., Laute, MA, Van Blercom, N., Damhaut, P., Goldman, S. and Hildebrand, J. (1997) Microdialysis-HPLC for plasma levodopa and metabolites monitoring in parkinsonian patients. Clin Chem, 43, pp. 740-744.
31. Bouhaddi, M., Vuillier, F., Fortrat, JO, Cappelle, S., Henriet, MT, Rumbach, L. and Regnard, J. (2004) Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: Involvement of L-dopa therapy. Auton Neurosci Basic Clin, 116, pp. 30-38.